This experiment was designed to investigate the possible involvement of angiotensin II (Ang II) and platelet-derived growth factor (PDGF) in the mechanism underlying stretch-induced proliferation of vascular smooth muscle cells (SMCs). SMCs from the rabbit aortic media were grown on polystyrene rubber-bottomed dishes coated with type I collagen. Cells were stretched cyclically by a vacuum-operated downward flexion of the culture dish bottom. A 1.4-to 1.6-fold increase in proliferation of SMCs was induced by cyclic stretching, as determined by [3H]-thymidine incorporation, in a stretch force-dependent manner in the range of 5 % to 15% elongation, 30 cycles/mmn for 24 h. Expression of PDGF-B chain mRNA was up-regulated in a time-dependent manner in the range of 2 to 24 h, 10% elongation, and 30 cycles/mm. Saralasin, a selective antagonist of Ang II, and captopril, an angiotensin I converting enzyme inhibitor, significantly suppressed the stretch-induced proliferation of SMCs. Blockade of angiotensinogen mRNA translation by antisense oligonucleotide inhibited proliferation under the mechanical strain. Stretch-induced proliferation was inhibited by 78% in the presense of anti-PDGF-AB neutralizing antibody. Increased expression of PDGF-B chain mRNA under the mechanical strain was inhibited by treatment with saralasin. Our results indicate that the stretch-induced proliferation of cultured SMCs is mediated at least in part via increased production of Ang II by the local renin-angiotensin system and a subsequent up-regulation of PDGF-B chain mRNA in an autocrine-paracrine manner. (Hypertens Res 1997; 20: 217-223) 
Key Words: angiotensin II, saralasin, captopril, antisense oligonucleotide, platelet-derived growth factor, smooth muscle cell, proliferation Blood vessels are continuously exposed to mechanical strain as a consequence of pulsation and shear stress caused by blood flow. Mechanical strain is one of the major determinants of the structure and function of blood vessels. The vascular wall is equipped with an adaptable, fine structure composed of endothelial cells, smooth muscle cells (SMCs), and fibroblasts that respond to an acute or chronic derangement of blood pressure and flow (1-3). Mechanical overloading to the vascular wall f ollowing hypertension initiates a series of biochemical events that have been postulated to form the basis for vascular lesions, as characterized by hypertrophy and hyperplasia of SMCs and deposition of extracellular matrix components (4) . The mechanism of this important vascular response is not known. Since most studies of the growth of SMCs have been performed under standard static conditions of cell culture, little is known about the role that cyclic stretch may play in prolif erative responses of SMCs. Cyclic mechanical strain reportedly increases cell number and DNA synthesis in cultured bone (5), epithelial (6), and endothelial cells (7). Wilson et al. demonstrated that mechanical strain induces mitogenic effects on the growth of SMCs due to the production and secretion of platelet-derived growth factor (PDGF) (8). However, the molecular mechanism by which SMCs sense mechanical strain and respond by increased cell growth is not well understood. Evidence supports the participation of vasoactive substances, growth factors, and inflammatory mediators in the pathophysiology of vascular lesions, such as those associated with atherosclerosis and vascular remodeling, that are induced by hemodynamic stimuli (1-3). A growing body of evidence suggests that tissues including the blood vessels (9, 10) and the heart (I1, 12) contain endogenous renin-angiotensin systems of their own. Angiotensin II (Ang II) reportedly stimulates cell growth (13, 14) and collagen synthesis (15) of cultured SMCs, and acts as an initial mediator for stretch-induced hypertrophy of cardiac myocytes (16) (17) (18) . The objective of this study was to examine the possible involvement of Ang II and PDGF in the mechanism of the stretch-induced proliferation of cultured SMCs.
Methods
Cell Culture A primary culture of smooth muscle cells (SMCs) was obtained from the aortic media of 12-wk-old, male rabbits. SMCs were isolated enzymatically as described elsewhere (19) . The cells were characterized as smooth muscle cells based on their alignment, growth in "hills and valleys," and a positive immunoreaction to smooth muscle-specific a-actin monoclonal antibody (Sigma Immunochemicals, St. Louis, MO). SMCs were cultured in Dulbecco's modified Eagle's medium (DMEM, Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with 5% (vol/vol) heat-inactivated fetal bovine serum (FBS, Gibco BRL, Grand Island, NY), 4 mM L-glutamine (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) and 5 mM sodium bicarbonate. SMCs were serially passaged when confluent with 0.25% trypsin and 1mM ethylenediaminetetraacetic acid (EDTA), and were used between passages 4 and 13. SMCs were cultivated in a humidified 5% CO2/95% air atmosphere at 37°C. The medium was changed every 3 days. SMCs were seeded on sixwell polystyrene-bottomed culture plates (29.45 cm2/well) coated with type I collagen (Flex I, Flexcell International Corp., McKeesport, PA) at a density of 104 to 5 X 104 cells/well. After cells reached subconfluency, they were made quiescent for 24 h before stretching by replacing the medium with serum-free DMEM supplemented with 4 mM L-glutamine and 5 mM sodium bicarbonate.
In vitro Strain Unit
The stretch force-generating device was a Flexercell® FX-2000 (Flexcell International Corp., McKeesport, PA) (20, 21) . It consists of a computer-controlled vacuum unit that provides a hemispherically downward deformation to a flexible-polystyrene sheet of the culture dish bottom, coated with type I collagen (Flex I®, Flexcell International Corp.). Application of the vacuum results in a nonhomogenous strain profile that is maximum at the periphery, with a geometric decline towards zero at the center of the Flex I culture dish bottom (21) . SMCs were subjected to a mechanical deformation at elongation rates of 5%, 10% and 20% , 30 cycles/min at 37°C in a CO2 incubator. Non-stretched control cells were grown in the same culture dish. To determine the presence of cellular injury due to mechanical strain, viability of the stretched cells was constantly monitored by the trypan blue dye exclusion test (22) . The attached cells showed a viability of 91 ± 4% and 90 ± 5% in the stretched and non-stretched regimens, respectively.
The viability of stretched SMCs did not differ from that of non-stretched cells during the present experiments.
[3H]-Thimidine Incorporation SMCs were subjected to cyclic stretching at a rate of 5%, 10%, and 15% elongation, 30 cycles/min for 24 h. Twelve hours before cessation of stretching, [3H]-thymidine (1pCi/ml) (methyl [3Hj-thymidine, 87.7 Ci/m mol, Dupont/New England Nuclear, Boston, MA) was added to the culture medium. Cells were washed twice with phosphate-buffered saline and treated with ice-cold 5% trichloroacetic acid for 20 min (23) . Cells were solubilized in 0.25 N NaOH, 0.1% sodium lauryl sulfate (SDS) and then neutralized with 1.0 N HCI. Radioactivity of the samples was measured in Aquasol (Dupont/New England Nuclear). Cell growth was determined in the presence and absence of [Sari,
, or a goat anti-PDGF-AB neutralizing antibody (20 1ug/ml) (Upstate Biotechnology Inc., NY). As control for treatment with anti-PDGF-AB antibody, normal goat immunoglobulin (IgG) was used (20 pg/ml) (Sigma Chemical Co.).
Trans f ection o f Antisense Oligonucleotide
Phosphorothioate-protected antisense oligonucleotide was transfected to cultured SMCs to suppress the translation of angiotensinogen mRNA. Briefly, unmodified DNA oligonucleotide was synthesized on an automated solid-phase synthesizer (Applied Biosystems Inc., Foster City, CA) using standard phosphoramidate chemistry with oxidation by iodine (Custom Oligonucleotide Synthesis, TOYOBO Co., Ltd., Osaka). The sequence of antisense oligonucleotide used in the present study was 30-mer human preangiotensinogen starting from position 934 to 963 (5'-CAC-TGA-GGT-GCT-GTT-GTC-CAC-CCA-GAA-CTC-3') (24) . The sequence of this region is highly conserved and homologous in humans and rats. Sense oligonucleotide was synthesized for control. Oligonucleotides were dissolved in double-distilled water (100 pM) and kept at -20°C until use.
A cationic liposome-mediated transfection (Lipofectin) method (25) was used to introduce antisense and sense oligonucleotides into SMCs. Fifteen microliters of oligonucleotide dissolved in 2.5 ml of Opti-MEM I and 0.25 ml of LipofectinTM Reagent DOTMA (1 mg/ml) (N[1-(2,3 dioleyoxy) propyl]-N,N,N trimethylammonium chloride) (BRL Life Technologies, Gaithersburg, MD) dissolved in 2.5 ml of Opti-MEM I were gently mixed and incubated for 15 min at room temperature. Subconfluent cells were washed three times with Opti-MEM I (BRL Life Technologies, Gaithersburg, MD) prewarmed to 37°C. The oligonucleotide-liposome complex (0.2 ml) was then added to each well of the culture dishes (0.8 ml of Opti-MEM I) and incubated for 15 h at 37°C in 5% CO2. Sense oligonucleotide was used for control. The oligonucle-otide-containing medium was replaced with serumfree DMEM supplemented with 4 mM L-glutamine for assay of [3H]-thymidine incorporation. Oligonucleotide efficiency was estimated immunocytochemically with the use of digoxigenin-labeled sense or antisense oligonucleotide. More than 90% of transferted SMCs yielded a positive reaction for the immunostaining with anti-digoxigenin antibody.
Northern Blot Analyses Total RNA was extracted from stretched and nonstretched SMCs using TRIzo1TM reagent (Gibco BRL, Grand Island, NY). RNA concentration and relative purity were determined by measuring absorbance at 260 nm and calculating the ratio of the absorbance at 260 nm relative to that at 280 nm. Total RNA (25 ,cg/lane) was fractionated by electrophoresis through 1.5% agarose gels and transferred to a nylon membrane (Hybond-N, Amersham, UK). Nucleic acids were immobilized by ultraviolet irradiation. The membranes were prehybridized at 42°C for 2 h in a buffer containing 50% formamide, 5 X SSPE (1 X SSPE equals 0.15 M sodium chloride, 0.01 M NaH2PO4H2O, 1 mM EDTA, pH 7.4), 0.5% SDS, 0.5% skimmed milk, 10% dextran sulfate and 100 pg/ml denatured salmon sperm DNA. The blots were hybridized in the same buffer with cDNA probes for PDGF-B chain mRNA labeled with [32Pj-dCTP by random hexanucleotide priming (Random Priming Kit, Boehringer Mannheim GmbH) at 42°C overnight according to the manufacturer's protocol (26) . The blots were then washed in 2 X SSC (1 X SSC equals 0.15 M sodium chloride, 15 mM sodium citrate, pH 7.0), 0.1% SDS at 65°C for 30 min, and then further in 0.1 X SSC, 0.1% SDS at 65°C for 30 min. Finally, the membranes were exposed to X-ray film (Kodak X-AR) at --80°C.
Statistical Analysis
The results are expressed as the mean (M) ± standard deviation (SD). Student's unpaired t-test and an analysis of multiple variance by Scheffe's method were used for statistical comparison. A p value less than 0.05 was considered to indicate statistical significance.
Results
Cell Growth Cyclic stretching of smooth muscle cells (SMCs) yielded a 1.4-to 1.6-fold increase in [3H]-thymidine incorporation at a rate of 5 % to 15% elongation, 30 cycles/mmn for 24 h (Fig. 1, p < 0.01). [3H]-thymidine incorporation reached a plateau at 10% elongation. Experiments were so designed as to be carried out under the mechanical strain at 10% elongation, 30 cycles/mmn for 24 h throughout the present study.
Effects of Saralasin and Captopril
As shown in Fig. 2 and 3 , the stretch-induced [3H]-thymidine incorporation was inhibited to degrees of 51% and 61% by treatment with saralasin (10-5 M) and captopril (10-5 M), respectively (p < 0.01). No significant decrease was noted in non-stretched SMCs treated with either saralasin or Captopril. Blockade o f Angiotensinogen mRNA Translation [3H]-thymidine incorporation was suppressed to a degree of 68% in stretched SMCs transfected with antisense oliginucleotide for angiotensinogen mRNA, as compared with their sense oligonucleotidetransfected counterparts (Fig. 4, p < 0.01) . No significant difference in [3H]-thymidine incorporation was detected in a static, non-stretched condition between SMCs transfected with sense oligonucleotide and those with antisense oligonucleotide for angiotensinogen mRNA.
Expression o f PDGF B Chain mRNAs
Northern blot analysis revealed significant increases in the expression of PDGF-B chain mRNA in a time-dependent manner from 2 to 24 h of mechanical strain (Fig. 5) . The elevated expression of PD GF-B chain mRNA induced by stretching for 12 h was suppressed by treatment with saralasin (10-5 M) (Fig. 6) . Effect o f Anti-PDGF AB Neutralizing Antibody Treatment with anti-PDGF-AB neutralizing antibody (20 pg/ml) significantly inhibited stretch-induced [31-I]-thymidine incorporation to a degree of 78%, as compared with normal IgG-treated control (20 ,aglml) (Fig. 7, p < 0.01) . Anti-PDGF-AB neutralizing antibody (20 pg/ml) and normal IgG (20 ag/ml) did not significantly change [3H}-thymidine incorporation in non-stretched SMCs.
Discussion
The present study demonstrated that cyclic mechanical strain stimulated proliferation of cultured smooth muscle cells (SMCs) in a stretch force-dependent manner as determined by [3H]-thymidine i ncorporation. A 1.6-fold increase in [3H]-thymidine incorporation was found under mechanical strain for 24 h at a rate of 10% elongation, 30 cycles/min. We showed that under the mechanical strain an increase in [3H]-thymidine incorporation was significantly inhibited to between 51% and 68% by saralasin, a selective antagonist of angiotensin II (Ang II), captopril, an angiotensin I converting enzyme inhibitor, or an antisense oligonucleotide to angiotensinogen mRNA. Since saralasin concurrently inhibited the expression of PDGF-B chain mRNA in stretched SMCs, Ang II may act as an initial mediator for the stretch-induced proliferation of SMCs. We further showed that the stretch-induced proliferation was inhibited to 78% by an anti-PDGF-AB neutralizing antibody, indicating that the release of PDGF underlies the mechanism by which mechanical strain induces cell proliferation. Wilson et al. have reported that the mitogenic effects of mechanical strain (60 cycles/min) in newborn rat SMCs were suppressed by 50% and 75% after treatment with neutralizing antibodies to PDGF-AB and -AA, respectively (8). They were able to demonstrate a significant increase in the expression of several isoforms of PDGF by Western blots after mechanical stretching for 48 h. Sudhir et al. have shown potentiation of the mitogenic activity of Ang II under mechanical strain and inhibition of this activity by neutralizing antibodies to PDGF (27) . In a study by Yang et al., PDGF had additive effects on [3H]-thymidine incorporation in coronary smooth muscle cells subjected to mechanical strain (28) .
An autocrine-paracrine network, including the participation of local vasoactive substances and growth factors, has been proposed in cardiovascular disorders (1-3). Mechanical stimuli to cell growth may be transduced to some extent through an autocrine-paracrine mechanism involving local production of PDGF from cultured SMCs. Ang II reportedly responds as a prime mediator via the ATl receptor for the stretch-induced hypertrophy of cardiac myocytes (16, 17) . The sequential activation by Ang II of proto-oncogenes, such as c-myc, and of autocrine growth factors, such as PDGF-A chain, basic fibroblast growth factor (bFGF), and TGF-~91, is also involved in the hypertrophy and hyperplasia of SMCs (29) (30) (31) . Many of these factors share a common pathway of signal transduction and may mimic or enhance the effects of each other on cell growth. The stretch-induced cell growth may be controlled by an autocrine-paracrine mechanism, with participation of local vasoactive substances and growth factors in a synergistic, antagonistic manner, or may involve an interaction between these factors in a complex regulatory mechanism (29, (31) (32) (33) . However, the direct effect of stretch force on cultured SMCs also should be considered, since stretch signals may be transmitted at multiple sites via cation channels on the cell membrane (34, 35) and directly via integrins to cytoskeletal proteins (36) . Various extracellular signals are known to trigger the induction of immediate-early genes or protooncogenes. Proto-oncogenes such as c fos, c jun, and c-myc are inducible in cardiac myocytes and non-myocytes (16) as early as 30 min after cyclic stretching. Cellular processes coupling with shortterm, transient signals from a mechanical strain may lead to long-term alterations of phenotype by regulating the target gene expression of selected molecules, such as angiotensinogen, angiotensin I converting enzyme, and PDGF.
A basic pathological feature of vascular disease is the thickening of vessel walls and formation of neointimal lesions, attributable to the migration and proliferation of SMCs and macrophages. The delicate balance between growth and cell death is involved in normal development and pathological conditions of blood vessels. Recent studies show that a decrease in apoptotic cells characterizes hu- man atherosclerosis and rat vascular injury (37) . Many vasoactive substances, such as Ang II and PD GF, are now known to function as growth factors that promote cell survival and prevent apoptosis in vessel-wall cells (38, 39) . Increased expression of PDGF under mechanical strain may contribute in a synergistic way to cell proliferation by exerting growth promoting and anti-apoptotic effects on SMCs. Yamada et al. recently reported that proapoptotic effects of Ang II are mediated by AT2 receptors (40) . Ang II may have a dual effect on cell growth, either stimulatory or inhibitory, produced by alteration of AT1 and AT2 receptor expression in response to hemodynamic stimuli in blood vessels (41, 42) .
In summary, our data indicate that Ang II acts as an initial mediator for stimuli of mechanical stretch. This action of Ang II is followed by PDGF secretion, which results in proliferation of SMCs in an autocrine-paracrine manner. However, regulatory mechanisms of the stretch-induced cell growth of SMCs may involve the interaction of local vasoactive substances and growth factors other than Ang II and PDGF (43) . The elucidation of this mechanism at the cellular and molecular levels may provide new insights into the pathogenesis of vascular lesions. 
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